Pulmonary Hypertension - Pulmonary Diseases and Critical Care

Pulmonary Hypertension Program

University Hospital is home to South Texas’s largest and most experienced comprehensive Pulmonary Hypertension Program, where Dr. Rodolfo Estrada (UT Health San Antonio Pulmonary fellowship graduate 2019) serves as the medical director. UT Health San Antonio provides a full range of pulmonary hypertension diagnostics and has expertise in the management with FDA approved PH therapies.

Selected publications

Estrada RA, Auger WR, Sahay S. Chronic Thromboembolic Pulmonary Hypertension. JAMA. 2024 Feb 26. doi: 10.1001/jama.2023.24265. Epub ahead of print. PMID: 38407914.
Estrada RA, Sahay S. Insulin-like growth factor binding protein-4: The quest for the breakthrough biomarker in pulmonary arterial hypertension. Pulm Circ. 2023 Jun 20;13(2):e12252. doi: 10.1002/pul2.12252. PMID: 37346965; PMCID: PMC10281014.
Estrada RA. In symptomatic PAH, adding sotatercept to stable background therapy improved 6-min walk distance at 24 wk. Ann Intern Med. 2023 Jun;176(6):JC69. doi: 10.7326/J23-0034. Epub 2023 Jun 6. PMID: 37276594.